Western pharma's strategic role in China

Apr 23, 2015 Tags: Pharma Investment

Cross-border partnering and corporate investment activity are exploding in China, with major pharma leading the way. But regulatory and compliance hurdles remain a challenge to multinational companies bringing their products to China. This dynamic environment is rapidly changing the role of Western pharma in China. Senior executives from global pharma examine how the rapidly changing landscape in China is driving their companies to adapt new R&D models.

Moderator: Greg B. ScottChinaBio® Group